These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17278126)

  • 1. Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.
    Odes S; Friger M; Vardi H; Claessens G; Bossuyt X; Riis L; Munkholm P; Wolters F; Yona H; Hoie O; Beltrami M; Tsianos E; Katsanos K; Mouzas I; Clofent J; Monteiro E; Messori A; Politi P; O'Morain C; Limonard C; Russel M; Vatn M; Moum B; Stockbrugger R; Vermeire S;
    Inflamm Bowel Dis; 2007 Jul; 13(7):874-81. PubMed ID: 17278126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
    Dassopoulos T; Frangakis C; Cruz-Correa M; Talor MV; Burek CL; Datta L; Nouvet F; Bayless TM; Brant SR
    Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2/CARD15 Mutations among Bedouin Arabs with Inflammatory Bowel Disease: Frequency and Phenotype Correlation.
    Abu Freha N; Badarna W; Abu Tailakh M; Abu Kaf H; Fich A; Schwartz D; Segal A; Elkrinawi J; Karban A
    Isr Med Assoc J; 2018 Nov; 20(11):695-699. PubMed ID: 30430799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
    Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F
    Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease.
    Vavassori P; Borgiani P; Biancone L; D'Apice MR; Blanco Gdel V; Vallo L; De Nigris F; Monteleone I; Monteleone G; Pallone F; Novelli G
    Inflamm Bowel Dis; 2004 Mar; 10(2):116-21. PubMed ID: 15168811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.
    Azzam N; Nounou H; Alharbi O; Aljebreen A; Shalaby M
    Int J Mol Sci; 2012; 13(4):4268-4280. PubMed ID: 22605977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
    Cukovic-Cavka S; Vermeire S; Hrstic I; Claessens G; Kolacek S; Jakic-Razumovic J; Krznaric Z; Grubelic K; Radic D; Misak Z; Jadresin O; Rutgeerts P; Vucelic B
    Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):895-9. PubMed ID: 16825909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in
    Siddique I; Mustafa AS; Khan I; Ziyab AH; Altarrah M; Sulaiman R; Kadungothayil N; Shaheed F
    Saudi J Gastroenterol; 2021; 27(4):240-248. PubMed ID: 34380868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.
    Dassopoulos T; Nguyen GC; Talor MV; Datta LW; Isaacs KL; Lewis JD; Gold MS; Valentine JF; Smoot DT; Harris ML; Oliva-Hemker M; Bayless TM; ; Burek CL; Brant SR
    Am J Gastroenterol; 2010 Feb; 105(2):378-86. PubMed ID: 19826411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease].
    Tamzaourte M; Errabih I; Krami H; Maha F; Maria L; Benzzoubeir N; Ouazzani L; Sefiani A; Ouazzani H
    Pan Afr Med J; 2017; 27():116. PubMed ID: 28819537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population.
    Nagy Z; Karádi O; Rumi G; Rumi G; Pár A; Mózsik G; Czirják L; Süto G
    Ann N Y Acad Sci; 2005 Jun; 1051():45-51. PubMed ID: 16126943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.
    Halfvarson J; Standaert-Vitse A; Järnerot G; Sendid B; Jouault T; Bodin L; Duhamel A; Colombel JF; Tysk C; Poulain D
    Gut; 2005 Sep; 54(9):1237-43. PubMed ID: 15863472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn's disease: lessons from the Israeli Arab Crohn's disease cohort.
    Karban A; Atia O; Leitersdorf E; Shahbari A; Sbeit W; Ackerman Z; Mualem R; Levine A; Nesher S; Safadi R; Eliakim R
    Dig Dis Sci; 2005 Sep; 50(9):1692-7. PubMed ID: 16133971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.
    Salkic NN; Adler G; Zawada I; Alibegovic E; Karakiewicz B; Kozlowska-Wiechowska A; Wasilewicz M; Sulzyc-Bielicka V; Bielicki D
    Bosn J Basic Med Sci; 2015 May; 15(2):67-72. PubMed ID: 26042516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels.
    Vasseur F; Sendid B; Jouault T; Standaert-Vitse A; Dubuquoy L; Francois N; Gower-Rousseau C; Desreumaux P; Broly F; Vermeire S; Colombel JF; Poulain D
    Inflamm Bowel Dis; 2012 Mar; 18(3):430-8. PubMed ID: 21739538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
    Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
    Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.